Company Overview of Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc., an early stage biotechnology company, develops anti-inflammatory drugs in the areas of age-related macular degeneration, atherosclerosis, uveitis, rheumatoid arthritis, multiple sclerosis, and Alzheimer's disease. Its product includes POT-4, which is used for the treatment of age-related macular degeneration. Potentia Pharmaceuticals, Inc. was founded in 2001 and is based in Louisville, Kentucky.
201 East Jefferson Street
Louisville, KY 40202
Founded in 2001
Key Executives for Potentia Pharmaceuticals, Inc.
Similar Private Companies By Industry
|BioSamPle Solutions LLC||United States|
|Prexa Pharmaceuticals, Inc.||United States|
|BioCrystal, Ltd.||United States|
|ImClone Systems Corporation||United States|
|AOB Biotech Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Gainesville, FL | AstraZenecaPosted: May 23
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
To contact Potentia Pharmaceuticals, Inc., please visit www.potentiapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.